Stay Alert for Lybalvi, a New Combo Antipsychotic

January 2022

Rx Lybalvi combines the antipsychotic olanzapine with samidorphan, a new opioid antagonist...for schizophrenia or bipolar disorder.

Samidorphan is derived from naltrexone. But so far, using it alone hasn't panned out for alcohol use disorder or other conditions.

In Lybalvi, the idea is that samidorphan may lessen weight gain from olanzapine...possibly by blocking opioid receptors that regulate appetite.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote